Skip to main content
SpringerLink
Log in

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248

    Article  PubMed  Google Scholar 

  2. Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 148:1418–1426

    PubMed  CAS  Google Scholar 

  3. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, R U (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131:954–963

    Article  PubMed  CAS  Google Scholar 

  4. Meduri G, Golden E, Umberger R (2009) Randomized clinical trial evaluating the effects of low-dose prolonged hydrocortisone infusion on resolution of MODS in severe sepsis. Chest 136:154 suppl

    Article  Google Scholar 

  5. Marik PE, Pastores S, Annane D, Meduri G, Sprung C, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga GP, Bokhari F, Vogeser M (2008) Clinical practice guidelines for the diagnosis and management of corticosteroid insufficiency in critical illness: recommendations of an international task force. Crit Care Med 36:1937–1949

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study was funded by Baptist Memorial Health Care Foundation and the Assisi Foundation of Memphis.

Author information

Authors and Affiliations

  1. Veterans Affairs Medical Center, Memphis, TN, USA

    Reba Umberger & G. Umberto Meduri

  2. Baptist Memorial Hospital, Memphis, TN, USA

    Emmel Golden

  3. Ospedale di Trieste, Trieste, Italy

    Marco Confalonieri

  4. Division of Pulmonary, Critical Care, and Sleep Medicine, University of Tennessee Health Science Center, Memphis, TN, USA

    Qurrat-Ul-Ain Nawab & G. Umberto Meduri

Authors
  1. Qurrat-Ul-Ain Nawab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmel Golden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Confalonieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reba Umberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Umberto Meduri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Umberto Meduri.

Additional information

All authors contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nawab, QUA., Golden, E., Confalonieri, M. et al. Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement. Intensive Care Med 37, 1553–1554 (2011). https://doi.org/10.1007/s00134-011-2274-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-011-2274-5

Keywords

Search

Navigation